Fairvalue-Calculator Fairvalue-Calculator
EN DE

i-SENS, Inc (099190) Fair Value & Analysis

Healthcare · KR · Market cap 455B KRW

Price15,280 KRW
Fair Value16,403 KRW
Upside+7.4%
Quality89/100
Evidence: Low Range 16,403 KRW – 22,793 KRW

Fair value as of: Jun 24, 2026

Analysis

i-SENS, Inc (099190) currently trades at 15,280 KRW, while our model-based Fair Value estimate is 16,403 KRW — implying the stock looks roughly 7.4% undervalued today. We read business quality at 89/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe. The company was founded in 2000 and is headquartered in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

InBody Co (041830) +19% Value Added Technology Co (043150) +238% Mediana Co (041920) +6% Meta Biomed Co (059210) +176% Sewoon Medical Co (100700) +180% Medicon Hellas S.A (MEDIC) +5%

Frequently asked questions

Is i-SENS, Inc (099190) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 16,403 KRW versus a price of 15,280 KRW — about +7% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 099190?
Our 21-model fair value for i-SENS, Inc is 16,403 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 15,280 KRW.
What is the quality score of 099190?
i-SENS, Inc has a Quality Score of 89/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.